Methylphenidate-Associated Creatine Kinase Level Elevation
- PMID: 38976538
- DOI: 10.1097/MJT.0000000000001701
Methylphenidate-Associated Creatine Kinase Level Elevation
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Jaeschke RR, Sujkowska E, Sowa-Kućma M. Methylphenidate for attention- deficit/hyperactivity disorder in adults: a narrative review. Psychopharmacology (Berl). 2021;238:2667–2691.
-
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
-
- Shaikh S, Gonzalez-Zapata A, Mujeeb A, et al. Asymptomatic HyperCKemia: a diagnostic trap. Cureus. 2021;13:e12791.
-
- Leong L, Shimomura SK. Methylphenidate rhabdomyolysis. Drug Intell Clin Pharm. 1979;13:161–162.
-
- Ehara H, Maegaki Y, Takeshita K. Neuroleptic malignant syndrome and methylphenidate. Pediatr Neurol. 1998;19:299–301.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources